过去一年中添加的文章，按日期排序
[PDF][PDF] Follicular cell-derived thyroid carcinomas harboring novel genetic BRAFNON-V600E mutations: real-world data obtained using a multigene panel
JL von Ammon¹, GJR Machado¹, RRC da Matta¹… - researchgate.net
2 天前 - … in adult thyroid cancer is harbored in the BRAF gene, ie, the BRAFV600E mutation
(15,16)… in 40% of the tumors harboring a BRAFV600E mutation but was absent in tumors with …
(15,16)… in 40% of the tumors harboring a BRAFV600E mutation but was absent in tumors with …
[HTML][HTML] Diffuse large B‐cell lymphoma with BRAF V600E mutation mimicking thyroid carcinoma in fine‐needle aspiration: A diagnostic pitfall
L Xu, DD Huang, J Wang, Q You, F Yu - Clinical Case Reports, 2024 - ncbi.nlm.nih.gov
16 天前 - … (C) Amplification refractory mutation system PCR (ARMS‐PCR) showed BRAFV600E
mutation in both FNAC and subsequent excision specimen. (D) Hematoxylin and eosin (…
mutation in both FNAC and subsequent excision specimen. (D) Hematoxylin and eosin (…
[引用][C] 1931P Phase II study of PDR001 in combination with MAPK pathway inhibitors in patients with radioactive-refractory differentiated thyroid cancer (DTC)
W Wong, EJ Sherman, A Kriplani, L Michel… - Annals of …, 2024 - annalsofoncology.org
20 天前 - Background MAPK inhibition may impart immune stimulatory effects and enhance
expression of putative tumor antigens in differentiated thyroid cancer (DTC). We hypothesize …
expression of putative tumor antigens in differentiated thyroid cancer (DTC). We hypothesize …
[引用][C] 1929P Dabrafenib and trametinib (D+ T) in BRAFV600E differentiated thyroid cancer: A real-world experience in Italy
LD Locati, E Colombo, L Fugazzola… - Annals of …, 2024 - annalsofoncology.org
20 天前 - … Lenvatinib is the first line for radioiodine resistant differentiated thyroid cancer (RAIR-…
BRAFV600E mutation is the most common genomic alteration in papillary thyroid cancer (…
BRAFV600E mutation is the most common genomic alteration in papillary thyroid cancer (…
Pronosthyc: prognostic factors in radioiodine refractory differentiated thyroid cancer with distant metastases, a multicentric study from a french network of referral …
A Sagnella, H Lasolle, Y Godbert, CC Do… - Endocrine …, 2024 - endocrine-abstracts.org
26 天前 - Background: Radioiodine-refractory differentiated thyroid cancer (RAI-R DTC)
patients with distant metastases show poor survival rates. However, patients’ outcome can be …
patients with distant metastases show poor survival rates. However, patients’ outcome can be …
BRAFV600E/p-ERK/p-DRP1 (Ser616) Promotes Tumor Progression and Reprogramming of Glucose Metabolism in Papillary Thyroid Cancer
S Wen, Y Wu, JY Wang, Z Ni, S Dong, X Xie, Y Wang… - Thyroid, 2024 - liebertpub.com
31 天前 - … In summary, our findings confirm that the BRAFV600E mutation promotes glucose
metabolism reprogramming and mitochondrial fission in PTC through the BRAFV600E/pERK/…
metabolism reprogramming and mitochondrial fission in PTC through the BRAFV600E/pERK/…
… in Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP) and Invasive Follicular Variant of Papillary Thyroid Carcinoma (IFVPTC)
M Mohebbi, MA Yaghoubi, A Moradi… - Current Cancer …, 2024 - ingentaconnect.com
44 天前 - … analysis of the BRAFV600E mutation and the cytomorphological features of an
FNA biopsy specimen before the detection of surgical tissue samples and thyroid ultrasound in …
FNA biopsy specimen before the detection of surgical tissue samples and thyroid ultrasound in …
Modified TI-RADS Coupled with BRAFV600E Enhances Diagnostic Efficiency in Papillary Thyroid Carcinoma: Prospective Study
J Wang, H Cheng, X Li - International Journal of General Medicine, 2024 - Taylor & Francis
73 天前 - … diagnosis of thyroid cancer hold exceptional importance. This study aimed to
determine the efficacy of a modified TI-RADS and BRAFV600E mutation testing for thyroid cancer (…
determine the efficacy of a modified TI-RADS and BRAFV600E mutation testing for thyroid cancer (…
[PDF][PDF] THE STUDY OF CHANGING THE HORMONE LEVELS AND BRAF^(V600E) MUTATION WITH THYROID CANCER IN MONGOLIA
S Okdoo, S Lkhagvadorj, M Malchinkhuu… - Journal of Data …, 2024 - researchgate.net
112 天前 - … In our study, most of the patients with BRAFV600E mutation in thyroid cancer had
a serum level of TSH, fT3, and fT4 within the normal reference ranges. Only one patient with …
a serum level of TSH, fT3, and fT4 within the normal reference ranges. Only one patient with …
[PDF][PDF] Prognostic Role of β-catenin/PTEN Expressions and Braf/Kras Mutations in Papillary Thyroid Carcinoma: Correlation with Response to Radioactive Iodine …
MT Hussien - secioj.journals.ekb.eg
114 天前 - … There was no significant relationship found between PTCs harboring BRAFV600E
mutation and pathological characteristics or responsiveness to RAI (P= 0.521). Conclusions: …
mutation and pathological characteristics or responsiveness to RAI (P= 0.521). Conclusions: …